Biotech ETF XBI (and IBB) recently began showing relative strength versus the broad US market.
It now has one of the strongest 6-month charts of any industry group.
On the other hand, our global algorithm picked out a stinker – the Philippines ETF (EPHE). After a great start to 2016, it has done very poorly relative to other world markets over the last couple of months.
If global investing is your shtick, you may want to look elsewhere.